Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations
Agentic AI improves clinical trial launch and operation operations by enabling continuous orchestration, early risk detection, adaptive intervention planning, and continuous optimization.
The article discusses how agentic AI can improve clinical trial design and operations by enabling continuous orchestration, early risk detection, adaptive intervention planning, and continuous optimization. These capabilities aim to streamline enrollment, reduce amendment costs, and improve patient matching using real‑world data. The piece highlights the need for human oversight, auditability, and bias mitigation in AI‑driven trial management.
Such capabilities can reduce protocol amendments, speed enrollment and shorten clinical trial timelines, ultimately enabling safer therapies to reach patients sooner.
Bizonyítékszint: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Kapcsolódó jelek
- A case report of advanced small intestinal stromal tumor with KIT gene mutation and BRCA2 deletion after multi-line treatments
- Review of Genomic Testing and SDH Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
- Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
- Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
- UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)